Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
mdpi.com A firstinhuman tolerability trial administering IV BPC-157 to healthy volunteers showed good safety profiles at doses up to 0.5 mg/kg, setting the stage for future clinical pharmacokinetic and safety assessments
They degrade quickly in the bloodstream unless protected by specialized delivery methods such as injections
1 daily dose (16,7gr) with the doser or diluted in water.
NexLife (our #1 pick) discloses both 503A and 503B partners.
Sparta Labs sells research-use-only materials
US$ 24.09
US$ 27.32
US$ 25.39
